Key result
In patients with eosinophilic myocarditis, treatment with prednisolone and etiology-specific therapies significantly improved clinical scores from 4.7 to 1.9 (p<0.05) and yielded an 86% survival rate.
Why the study?
Does prednisolone alongside etiology-specific treatment improve survival in patients with eosinophilic myocarditis?
Observational (n=7)
No
Does prednisolone alongside etiology-specific treatment improve survival in patients with eosinophilic myocarditis?
Absolute Event Rate: 1.9% vs 4.7%
p-value: p=<0.05
In a small case series, administration of prednisolone alongside etiology-specific treatment was associated with a high survival rate (86%) in patients with eosinophilic myocarditis.
No takes yet. Share an insight, caveat, or question.
May support prednisolone plus etiology-specific therapy in eosinophilic myocarditis; leaves open need for controlled trials before practice change.
Kawano et al. (2011) conducted an observational in Eosinophilic myocarditis (n=7). Prednisolone vs. Pre-treatment baseline was evaluated on Japanese Circulation Society guideline score (p=<0.05). In patients with eosinophilic myocarditis, treatment with prednisolone and etiology-specific therapies significantly improved clinical scores from 4.7 to 1.9 (p<0.05) and yielded an 86% survival rate.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: